SecBot SecBot
EFFECT ·Filed Oct 26, 2026

PCSA

Processa Pharmaceuticals, Inc.
BEARISH
Impact 6/10
Processed19h 4m ago SEC9999999995-26-003335
IPO/offering going effective

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-003335
Document: 9999999995-26-003335-index.html9999999995-26-003335
Document: 9999999995-26-003335.txt9999999995-26-003335
14 reports for PCSA
Performance horizon
64% Hit rate @ T+5 7 of 11 directional calls Went positive at some point 9 of 11 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.79 (+0.83%)
Oct 22, 2026
4d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.79 (−0.83%)
Oct 9, 2026
17d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.79 (+5.53%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.79 (−11.58%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.79 (−16.90%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.79 (−38.53%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 8h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh PCSA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access